Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Deloitte
Harvard Business School
Cerilliant
Farmers Insurance
US Army
Julphar
QuintilesIMS
Cantor Fitzgerald

Generated: December 17, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: FLUDEOXYGLUCOSE F-18

« Back to Dashboard

FLUDEOXYGLUCOSE F-18

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Biomedcl Res Fdn FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203710 ANDA Biomedical Research Foundation of Northwest Louisiana 24562-001-30 30 mL in 1 VIAL, GLASS (24562-001-30)
Biomedcl Res Fdn FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203837 ANDA Biomedical Research Foundation of Northwest Louisiana 24562-003-30 30 mL in 1 VIAL, GLASS (24562-003-30)
Brigham Womens FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203816 ANDA BRIGHAM AND WOMEN`S HOSPITAL, INC., THE 24450-647-30 30 mL in 1 VIAL, MULTI-DOSE (24450-647-30)
Cardinal Health 414 FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203603 ANDA Cardinal Health 414, LLC 65857-100-30 30 mL in 1 VIAL, GLASS (65857-100-30)
Childrens Hosp Mi FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 204385 ANDA Children's Hospital of Michigan 76167-001-30 30 mL in 1 VIAL, GLASS (76167-001-30)
Cpdc FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 204525 ANDA Centre for Probe Development and Commercialization 21731-647-01 .8 mL in 1 SYRINGE (21731-647-01)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Baxter
UBS
Argus Health
Accenture
Dow
McKinsey
Cipla
Express Scripts